Skip to main content
TipRanks
Go Ultimate75% OFF

Annexon Biosciences (ANNX) Ratios

1,429 Followers

Annexon Biosciences Ratios

ANNX's free cash flow for Q3 2026 was $-48.68M. For the 2026 fiscal year, ANNX's free cash flow was increased by $0.00 and operating cash flow was $-48.68M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio5.6810.3714.7211.1011.39
Quick Ratio5.6810.3714.7211.1011.39
Cash Ratio3.801.6212.566.263.44
Solvency Ratio-3.10-2.37-2.80-2.59-2.33
Operating Cash Flow Ratio-4.37-3.87-6.76-5.20-4.88
Short-Term Operating Cash Flow Coverage0.000.000.000.000.00
Net Current Asset Value$ 176.27M$ 259.50M$ 216.74M$ 194.20M$ 192.56M
Leverage Ratios
Debt-to-Assets Ratio0.090.080.110.120.12
Debt-to-Equity Ratio0.120.100.130.140.15
Debt-to-Capital Ratio0.110.090.110.120.13
Long-Term Debt-to-Capital Ratio0.000.000.000.000.00
Financial Leverage Ratio1.311.191.191.231.24
Debt Service Coverage Ratio0.000.000.000.000.00
Interest Coverage Ratio0.000.000.000.000.00
Debt to Market Cap0.000.000.000.000.00
Interest Debt Per Share0.170.210.410.600.90
Net Debt to EBITDA0.660.151.370.750.31
Profitability Margins
Gross Profit Margin0.00%0.00%0.00%0.00%0.00%
EBIT Margin0.00%0.00%0.00%0.00%0.00%
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
Operating Profit Margin0.00%0.00%0.00%0.00%0.00%
Pretax Profit Margin0.00%0.00%0.00%0.00%0.00%
Net Profit Margin0.00%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin0.00%0.00%0.00%0.00%0.00%
Net Income Per EBT100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT95.51%89.70%93.40%97.49%99.70%
Return on Assets (ROA)-74.46%-39.48%-45.10%-49.79%-45.40%
Return on Equity (ROE)-97.66%-47.15%-53.58%-61.40%-56.20%
Return on Capital Employed (ROCE)-92.11%-48.21%-51.38%-55.42%-49.27%
Return on Invested Capital (ROIC)-90.99%-47.84%-50.98%-55.14%-49.05%
Return on Tangible Assets-74.46%-39.48%-45.10%-49.79%-45.40%
Earnings Yield-26.55%-19.61%-39.07%-50.22%-29.60%
Efficiency Ratios
Receivables Turnover0.000.000.000.000.00
Payables Turnover0.250.330.000.000.00
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover0.000.000.000.000.00
Asset Turnover0.000.000.000.000.00
Working Capital Turnover Ratio0.000.000.000.000.00
Cash Conversion Cycle-1478.52-1101.760.000.000.00
Days of Sales Outstanding0.000.000.000.000.00
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding1478.521101.760.000.000.00
Operating Cycle0.000.000.000.000.00
Cash Flow Ratios
Operating Cash Flow Per Share-1.20-0.86-1.60-2.13-2.77
Free Cash Flow Per Share-1.20-0.86-1.60-2.25-2.81
Dividend Paid and CapEx Coverage Ratio-1360.26-7867.07-627.68-17.82-64.15
Capital Expenditure Coverage Ratio-1360.26-7867.07-627.68-17.82-64.15
Operating Cash Flow Coverage Ratio-7.11-4.07-3.86-3.54-3.07
Operating Cash Flow to Sales Ratio0.000.000.000.000.00
Free Cash Flow Yield-23.95%-16.74%-35.32%-43.46%-24.48%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-3.75-5.10-2.56-1.99-3.38
Price-to-Sales (P/S) Ratio0.000.000.000.000.00
Price-to-Book (P/B) Ratio3.682.401.371.221.90
Price-to-Free Cash Flow (P/FCF) Ratio-4.18-5.97-2.83-2.30-4.09
Price-to-Operating Cash Flow Ratio-4.18-5.97-2.84-2.43-4.15
Price-to-Earnings Growth (PEG) Ratio-0.110.120.080.090.35
Enterprise Value Multiple-3.14-5.08-1.06-1.22-3.11
Enterprise Value642.78M684.36M149.80M175.50M400.00M
EV to EBITDA-3.14-5.08-1.06-1.22-3.11
EV to Sales0.000.000.000.000.00
EV to Free Cash Flow-3.45-5.80-1.23-1.43-3.71
EV to Operating Cash Flow-3.45-5.80-1.24-1.51-3.77
Tangible Book Value Per Share1.362.133.314.236.05
Shareholders’ Equity Per Share1.362.133.314.236.05
Tax and Other Ratios
Effective Tax Rate0.000.000.000.000.00
Revenue Per Share0.000.000.000.000.00
Net Income Per Share-1.33-1.01-1.77-2.60-3.40
Tax Burden1.001.001.001.001.00
Interest Burden1.001.000.930.971.00
Research & Development to Revenue0.000.000.000.000.00
SG&A to Revenue0.000.000.000.000.00
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality0.900.850.900.820.81

Currency in USD